3,4-MDO-U-47700

3,4-MDO-U-47700

3,4-MDO-U-47700

Opioid analgesic designer drug

3,4-MDO-U-47700 is an opioid analgesic which has been sold as a designer drug, first appearing in 2017 after U-47700 itself was banned in various jurisdictions. It is less potent than U-47700 but is still a full agonist at the μ-opioid receptor, with slightly higher potency than morphine.[1][2][3] It is illegal in Virginia.[4]

Quick Facts Identifiers, CAS Number ...

See also

References

  1. [1]
    "3,4-metylendioxi-U-47700" (PDF). Åklagarmyndigheten. Sweden. 2019.
  2. [2]
    Popławska M, Bednarek E, Naumczuk B, Kozerski L, Błażewicz A (January 2021). "Identification and structure characterization of five synthetic opioids: 3, 4-methylenedioxy-U-47700, o-methyl-acetylfentanyl, 2-thiophenefentanyl, benzoylfentanyl and benzoylbenzylfentanyl". Forensic Toxicology. 39: 45–58. doi:10.1007/s11419-020-00539-6. S2CID 219935247.
  3. [3]
    Baumann MH, Tocco G, Papsun DM, Mohr AL, Fogarty MF, Krotulski AJ (November 2020). "U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market". Brain Sciences. 10 (11): 895. doi:10.3390/brainsci10110895. PMC 7700279. PMID 33238449.
  4. [4]
    "54.1-3446". Code of Virginia. Commonwealth of Virginia.



Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article 3,4-MDO-U-47700, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.